Ewenstein B M, Uehara H, Nisizawa T, Melvold R W, Kohn H I, Nathenson S G
Immunogenetics. 1980;11(4):383-95. doi: 10.1007/BF01567805.
Biochemical analyses of the H-2K-gene products of the C57BL/6 mutant strains, bm3 and bm11, have been carried out in order to characterize the structural relationships among these antigens. From comparative tryptic peptide mapping of cyanogen bromide fragments from the mutant and parent Kb glycoproteins and from preliminary amino-acid sequence analyses, a number of discrete differences have been discerned. Two sites of difference at amino residues 77 and 89 in the Kbm3 glycoprotein are noted relative to Kb. An alteration at residue 77 similar or identical to that seen in Kbm3 is present in the K antigen of the bm11 mutant. Because our techniques sample only 75 to 80 percent of the extracellular portion of H-2Kb, other undetected changes are possible. However, our present findings are most consistent with the conclusion that only very limited differences exist between mutant and parent molecules. Further, taken together with CML (cell-mediated-lymphocytotoxicity) reaction patterns (Melief et al. 1980), the biochemical data support the hypothesis that the proposed structural alterations in the Kb mutant glycoproteins are directly related to their observed immunological specificity.
为了描述这些抗原之间的结构关系,已对C57BL/6突变株bm3和bm11的H-2K基因产物进行了生化分析。通过对突变体和亲本Kb糖蛋白的溴化氰片段进行比较胰蛋白酶肽图谱分析以及初步的氨基酸序列分析,已发现了一些明显的差异。相对于Kb,在Kbm3糖蛋白的第77和89位氨基酸残基处有两个差异位点。在bm11突变体的K抗原中存在与Kbm3中所见相似或相同的第77位残基的改变。由于我们的技术仅对H-2Kb细胞外部分的75%至80%进行采样,因此可能存在其他未检测到的变化。然而,我们目前的发现最符合这样的结论,即突变体和亲本分子之间仅存在非常有限的差异。此外,结合细胞介导的淋巴细胞毒性(CML)反应模式(梅利夫等人,1980年),生化数据支持这样的假设,即Kb突变体糖蛋白中提出的结构改变与其观察到的免疫特异性直接相关。